Citations

Clear

9383 citation(s) found for "Thomas, PS".

Velopharyngeal Gap Size During Sustained Vowel Production Correlates With Perceptual Ratings of Hypernasality in Connected Speech
Chee-Williams, Jessica L. , Perry, Jamie L. , Bunton, Kate , Cordero, Kelly Nett , Snodgrass, Taylor D. , Singh, Davinder , Temkit, Hamy, Sitzman, Thomas J. , Singh, Davinder J , Sitzman, Thomas J , Chee-Williams, Jessica L , Cordero, Kelly N , Snodgrass, Taylor , Perry, Jamie L

Mayo Clinic

Journal of Speech, Language, and Hearing Research | August 22, 2024 | Volume: 67 | Issue: 9 | Pages: 2977-2986

10.1044/2024_jslhr-24-00221 | PMID 39173051 Get It

Purpose: The purpose of this study was to investigate the relationship between perceptual ratings of hypernasality made during connected speech and velopharyngeal (VP) gap size measured in millimeters in the sagittal plane during sustained vowel production using magnetic resonance imaging (MRI). Method: A retrospective cross-sectional analysis was completed. A subgroup of 110 participants from another study with an M age of 10.1 years presenting for management of VP insufficiency was included. Perceptual ratings of hypernasality during connected speech and measurement of gap size during sustained /i/ production on MRI were performed by raters blinded to the participants' medical and surgical history. Results: There was a moderate-to-strong, positive correlation ( r = .61; p < .001) between hypernasality ratings and VP gap size measured on MRI using sustained /i/. The odds of a higher hypernasality rating increased as the gap size increased (odds ratio = 1.34; 95% CI [1.20, 1.49]; p < .001). The predicted probability for hypernasality ratings of none/minimal/mild steadily decreased as the gap size increased indicating that lower ratings of hypernasality were associated with smaller gap sizes. For the rating of “moderate” hypernasality, the predicted probability of the rating steadily increased up to 8 mm and then decreased as the gap size continued to increase. The predicted probability for a hypernasality rating of “severe” consistently increased as the gap size increased. Conclusions: Hypernasality ratings made at the connected speech level were significantly associated with VP gap size as measured during sustained vowel production. These findings suggest sustained vowel production elicited on MRI may adequately characterize VP gap size in the evaluation of VP insufficiency.
Flow cytometry assay modifications: Recommendations for method validation based on CLSI H62 guidelines
Monaghan, Sara A. , Eck, Steven , Bunting, Silvia T., Dong, Xiangyang X., Durso, Robert J., Gonneau, Christèle , Hays, Amanda , Illingworth, Andrea , League, Stacy C., Linskens, Eleni , McCausland, Megan, McCloskey, Thomas W., Rolf, Nina , Wallace, Paul K. , Litwin, Virginia , Kern, Wolfgang , Deeb, George , Nash, Veronica, Olteanu, Horatiu , Wallace, Paul K , Olteanu, Horatiu , Kern, Wolfgang , Shi, Min

Mayo Clinic

Cytometry Part B: Clinical Cytometry | August 22, 2024 | Volume: 108 | Issue: 3 | Pages: 252-266

10.1002/cyto.b.22202 | PMID 39165120 Get It

AbstractThe Clinical and Laboratory Standards Institute (CLSI) H62—Validation of Assays Performed by Flow Cytometry guideline, released in 2021, provides recommendations for platform workflow and quality system essentials, instrument setup and standardization, assay development and optimization and fit‐for‐purpose analytical method validation. In addition, CLSI H62 includes some recommendations for the validation strategies after a validated flow cytometric method has been modified. This manuscript builds on those recommendations and discusses the impact of different types of assay modifications on assay performance. Recommendations regarding which validation parameters to evaluate depending on the type of modification are provided. The impact of assay modification on the assay's intended use is discussed. When recommending minor deviations from the CLSI H62 process for a laboratory‐initiated assay revision (e.g., specimen numbers for sensitivity, specificity, or precision studies), a rationale based on expert opinion is provided with the understanding that not every laboratory, assay type, and circumstance can be comprehensively addressed in this paper. These recommendations are meant as a practical recommendation and are not intended to be restrictive, prescriptive, or understood as necessarily sufficient to meet every specific requirement from regulatory bodies (e.g., FDA or New York State Department of Health).
Can optical evaluation distinguish between T1a and T1b esophageal adenocarcinoma: an international expert interobserver agreement study
Gupta, Sunil , Mandarino, Francesco Vito , Hourigan, Luke F. , Messmann, Helmut , Wallace, Michael B. , Repici, Alessandro , Haber, Gregory , Taylor, Andrew C.F., Waxman, Irving , Siersema, Peter D. , Lemmers, Arnaud , Bisschops, Raf , Mosko, Jeffrey D. , Pech, Oliver , Beyna, Torsten , Sharma, Prateek , Lee, Eric Y.T., Bourke, Michael J., group, on behalf of the study working, Bourke, Michael J. , Shahidi, Neal , Wallace, Michael B , Bisschops, Raf , Beyna, Torsten , Burgess, Nicholas G , Mandarino, Francesco Vito , Gupta, Sunil , Dinis‐Ribeiro, Mário , Pouw, Roos E. , Teshima, Christopher , Ragunath, Krish , Rösch, Thomas , group, on behalf of the study working

Mayo Clinic

Endoscopy | August 21, 2024 | Volume: 57 | Issue: 03 | Pages: 200-207

10.1055/a-2399-1401 | PMID 39168143 Get It

Background Piecemeal endoscopic mucosal resection (EMR) is an acceptable technique for T1a esophageal adenocarcinoma, but en bloc R0 excision is advocated for T1b disease as it may offer a potential cure and mitigate recurrence. Thus, distinguishing between T1a and T1b disease is imperative under current treatment paradigms. We investigated whether expert Barrett’s endoscopists could make this distinction based on optical evaluation. Methods Endoscopic images of histologically confirmed high grade dysplasia (HGD), T1a, and T1b disease (20 sets for each) were compiled from consecutive patients at a single institution. Each set contained four images including an overview, a close-up in high definition white light, a near-focus magnification image, and a narrow-band image. Experts predicted the histology for each set. Results 19 experts from 8 countries (Australia, USA, Italy, Netherlands, Germany, Canada, Belgium, and Portugal) participated. The majority had been practicing for > 20 years, with a median (interquartile range) annual case volume of 50 (18–75) for Barrett’s EMR and 25 (10–45) for Barrett’s endoscopic submucosal dissection. Esophageal adenocarcinoma (T1a/b) could be distinguished from HGD with a pooled sensitivity of 89.1 % (95 %CI 84.7–93.4). T1b adenocarcinoma could be predicted with a pooled sensitivity of 43.8 % (95 %CI 29.9–57.7). Fleiss’ kappa was 0.421 (95 %CI 0.399–0.442; P < 0.001), indicating fair-to-moderate agreement. Conclusions Expert Barrett’s endoscopists could reliably differentiate T1a/T1b esophageal adenocarcinoma from HGD. Despite fair-to-moderate agreement for T staging, T1b disease could not be reliably distinguished from T1a disease. This may impact clinical decision making and selection of endoscopic techniques.
Thrombolysis for Ischemic Stroke Despite Recent Ingestion of Direct Oral Anticoagulants – A Growing Dilemma Also in India
Meinel, Thomas R. , Menon, Bijoy K. , Fischer, Urs , Seiffge, David , Paramasivan, Naveen K, Fischer, Urs , Seiffge, David , Paramasivan, Naveen Kumar

Mayo Clinic

Annals of Indian Academy of Neurology | August 20, 2024 | Volume: 27 | Issue: 4 | Pages: 345-351

10.4103/aian.aian_524_24 | PMID 39196805 Get It

The administration of intravenous thrombolysis (IVT) for patients with acute ischemic stroke who have recently ingested direct oral anticoagulants (DOACs) presents a clinical challenge due to the perceived increased risk of intracranial hemorrhage (ICH). Traditional guidelines from the US and European authorities advise against IVT within 48 h of last DOAC ingestion, unless specific coagulation tests indicate safety. However, emerging observational studies suggest that IVT might be safe in selected patients. A US stroke registry study and a global multicenter cohort study both reported no significant increase in symptomatic ICH among patients on DOACs compared to those not on anticoagulants. A systematic review of all published observational studies further supported these findings, showing comparable bleeding rates and functional outcomes in DOAC-treated patients. Reversal agents like idarucizumab for dabigatran have demonstrated potential in facilitating safer IVT administration, though logistical and cost-related barriers limit their widespread use. The variability in global guidelines reflects differing approaches to risk assessment and resource availability, highlighting the need for individualized treatment decisions. In India, the increasing prevalence of atrial fibrillation and stroke as well as prescription of DOACs necessitate adapted guidelines that consider local health-care infrastructure. Despite the promising observational data, the lack of randomized controlled trials underscores the need for further research to establish robust evidence for IVT use in this context. Collaborative international efforts and inclusion of diverse patient populations in future studies will be crucial to refine treatment protocols and improve outcomes for stroke patients on DOACs.
Clues to revising the conventional diagnostic algorithm for endometriosis
Roman, Horace , Chapron, Charles , Golfier, François , Fauvet, R. , Delbos, Léa , Poilblanc, Mathieu, Lavoué, Vincent , Petit, E. , Perotte, Frédérique, Benjoar, Mikhael, Merlot, Benjamin , Dennis, Thomas , Boudy, Anne‐Sophie , Fedida, Benjamin, Lèguevaque, Pierre, Genre, Ludivine, Hennetier, Clothilde, Perrin, Morgane , Lucas, Nicolas, Roger, Claire‐Marie, Chantalat, Élodie , Collinet, Pierre , Descamps, Philippe , Bendifallah, Sofiane , Spiers, Andrew, Wasson, Megan , Rousset, Pascal , Akladios, Cherif Youssef , Crochet, Patrice , Fernandez, Hervé

Mayo Clinic

International Journal of Gynecology & Obstetrics | August 20, 2024 | Volume: 168 | Issue: 1 | Pages: 101-111

10.1002/ijgo.15840 | PMID 39161277 Get It

AbstractEndometriosis is a complex gynecologic disorder characterized primarily by symptoms of pelvic pain, infertility, and altered quality of life. National and international guidelines highlight the diagnostic difficulties and lack of conclusive diagnostic tools for endometriosis. Furthermore, guidelines are becoming questionable at an increasingly rapid rate as new diagnostic techniques emerge. This work aims to provide a knowledge synthesis of the relevance of various diagnostic tools and to assess areas of improvement of conventional algorithms. MEDLINE and Cochrane Library databases were searched from January 2021 to December 2023 using relevant key words. Articles evaluating the diagnostic relevance and performance of various tools were included and independently reviewed by the authors for eligibility. Included studies were assessed using the GRADE and QUADAS‐2 tools. Of the 4204 retrieved articles, 26 were included. While anamnesis and clinical examination do contribute to diagnostic accuracy, their level of evidence and impact on the diagnostic process remains limited. Although imaging techniques are recommended to investigate endometriosis, ultrasonography remains highly operator dependent. Magnetic resonance imaging appears to exhibit higher sensitivities than ultrasound. However, concerns persist with regards to the terminology, anatomical definition of lesions, and accuracies of both ultrasound and magnetic resonance imaging. Recently, several biological markers have been studied and cumulative evidence supports the contribution of noncoding RNAs to the diagnosis of endometriosis. Marginal improvements have been suggested for anamnesis, clinical examination, and imaging examinations. Conversely, some biomarkers, including the saliva microRNA signature for endometriosis, have emerged as diagnostic tools which inspire reflection on the revision of conventional diagnostic algorithms.
Loss of HD-PTP function results in lipodystrophy, defective cellular signaling and altered lipid homeostasis
Schultz, Destiny F. , Davies, Brian A., Payne, Johanna A., Martin, Cole P , Minard, Annabel Y. , Childs, Bennett G. , Jeganathan, Karthik B. , Sturmlechner, Ines , White, Thomas A. , Harkema, Liesbeth , Chen, Huiqin , Davies, Michael A. , Jachim, Sarah K. , Hu, Li , Deursen, Jan M. van , Billadeau, Daniel D. , Katzmann, David J. , Jeganathan, Karthik B , Sturmlechner, Ines , de Bruin, Alain , Harkema, Liesbeth , Jachim, Sarah , LeBrasseur, Nathan K , Piper, Robert C , Baker, Darren J , van Deursen, Jan M , Billadeau, Daniel D , Katzmann, David J , Zhang, Cheng , Bruin, Alain de , LeBrasseur, Nathan K. , Piper, Robert C. , Baker, Darren J.

Mayo Clinic

Journal of Cell Science | August 19, 2024 | Volume: 137 | Issue: 18 | Pages: No page available

10.1242/jcs.262032 | PMID 39155850 Get It

ABSTRACT His domain protein tyrosine phosphatase (HD-PTP; also known as PTPN23) facilitates function of the endosomal sorting complexes required for transport (ESCRTs) during multivesicular body (MVB) formation. To uncover its role in physiological homeostasis, embryonic lethality caused by a complete lack of HD-PTP was bypassed through generation of hypomorphic mice expressing reduced protein, resulting in animals that are viable into adulthood. These mice exhibited marked lipodystrophy and decreased receptor-mediated signaling within white adipose tissue (WAT), involving multiple prominent pathways including RAS/MAPK, phosphoinositide 3-kinase (PI3K)/AKT and receptor tyrosine kinases (RTKs), such as EGFR. EGFR signaling was dissected in vitro to assess the nature of defective signaling, revealing decreased trans-autophosphorylation and downstream effector activation, despite normal EGF binding. This corresponds to decreased plasma membrane cholesterol and increased lysosomal cholesterol, likely resulting from defective endosomal maturation necessary for cholesterol trafficking and homeostasis. The ESCRT components Vps4 and Hrs have previously been implicated in cholesterol homeostasis; thus, these findings expand knowledge on which ESCRT subunits are involved in cholesterol homeostasis and highlight a non-canonical role for HD-PTP in signal regulation and adipose tissue homeostasis.
The effect of radiation or chemotherapy on the local recurrence, overall survival, and distant metastasis in patients with myxofibrosarcoma: A systematic review
Tibbo, Meagan E. , Landau, Rebecca , Markowitz, Moses I. , Abuodeh, Yousef , Temple, H. Thomas , Crawford, Brooke , Abuodeh, Yousef

Mayo Clinic

Journal of Surgical Oncology | August 19, 2024 | Volume: 130 | Issue: 3 | Pages: 586-593

10.1002/jso.27782 | PMID 39155707 Get It

AbstractBackground and ObjectivesManagement of myxofibrosarcoma (MFS) is widely debated, and there is no consensus regarding the effect of adjuvant therapies on local recurrence (LR), distant metastasis (DM), or overall survival (OS). This study aims to determine the effect of adjuvant therapies on the aforementioned outcomes in patients with MFS.MethodsWe conducted a systematic review via Medline, PubMed, CINAHL, Cochrane, Embase, and Google Scholar. Therapeutic studies that reported LR, DM, and OS following adjuvant therapies in patients with MFS were included. Statistical analysis and creation of hazard ratios were performed using Revman 5.3 (Cochrane Collaboration).ResultsWe identified 301 studies, 10 of which were included in the final analysis. Neither chemotherapy nor radiation affected the rate of LR (p = 0.73 and 0.17, respectively) or OS (p = 0.97 and 0.27, respectively). Chemotherapy was significantly associated with lower rates of DM (p = 0.03); however, there was no association between radiation and DM (p = 0.67).ConclusionThere is a lack of consensus regarding the effect of neoadjuvant and adjuvant therapies on LR, DM, and OS in patients with MFS. Our systematic review found that radiation and chemotherapy were not significantly associated with OS or LR in patients with MFS. However, we identified a significant association between chemotherapy and lower rates of DM.
Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE
Dreyfus, Julien , Juarez-Casso, Fernando M. , Eixerés‐Esteve, Andrea , Bohbot, Yohann, Bazire, Baptiste , Flagiello, Michele , Riant, Elisabeth , Mbaki, Yannick, Tomasi, Jacques , Sénage, Thomas , Eyharts, Damien , Doguet, Fabien , Viau, F , Eggenspieler, Florian , Heuts, Samuel , Galloo, Xavier , Benfari, Giovanni , Badano, Luigi P. , Enriquez-Sarano, Maurice, Bartko, Philipp E. , Lim, Pascal , Radu, Costin , Bernick, Jordan , Wells, George A. , Tribouilloy, Christophe , Iung, Bernard , Bonis, Michele De , Juarez-Casso, Fernando, Bazire, Baptiste , Flagiello, Michele , Riant, Elisabeth , Tomasi, Jacques , Senage, Thomas , Eyharts, Damien , Doguet, Fabien , Viau, Florence , Heuts, Samuel , Sardari Nia, Peyman , Heitzinger, Gregor , Marsan, Nina Ajmone , Maisano, Francesco , Topilsky, Yan , Michelena, Hector, Selton-Suty, Christine , Habib, Gilbert , Lavie-Badie, Yoan , Modine, Thomas , Chan, Vincent , Donal, Erwan , Wells, George , Tribouilloy, Christophe , De Bonis, Michele , Messika-Zeitoun, David , Enriquez-Sarano, Maurice , Benfari, Giovanni , Sala, Alessandra , Carnero, Manuel , Rahmouni, Kenza , Coisne, Augustin , Heitzinger, Gregor , Marsan, Nina Ajmone , Muraru, Denisa , Maisano, Francesco , Topilsky, Yan , Michelena, Héctor I. , Enriquez‐Sarano, Maurice , Bax, Jeroen J. , Selton‐Suty, Christine , Habib, Gilbert , Modine, Thomas , Chan, Vincent , Tourneau, Thierry Le , Donal, Erwan , Obadia, Jean‐François , Crestanello, Juan A. , Messika–Zeitoun, David

Mayo Clinic

European Heart Journal | August 19, 2024 | Volume: 45 | Issue: 42 | Pages: 4512-4522

10.1093/eurheartj/ehae578 | PMID 39212387 Get It

Abstract Background and Aims Severe tricuspid regurgitation is associated with increased mortality rates, but benefit of its correction and ideal timing are not clearly determined. This study aimed to identify patient subsets who might benefit from the surgery. Methods In TRIGISTRY, an international cohort study of consecutive patients with severe isolated functional tricuspid regurgitation (33 centres, 10 countries), survival rates up to 10 years were compared between patients who underwent isolated tricuspid valve surgery (repair or replacement) and those conservatively managed, overall and according to TRI-SCORE category (low: ≤3, intermediate: 4–5, and high: ≥6). Results One thousand and two hundred seventeen were managed conservatively, and 551 underwent isolated tricuspid valve surgery (200 repairs and 351 replacements). TRI-SCORE distribution was 33% low, 32% intermediate, and 35% high. At 10 years, survival rates were similar between surgical and conservative management [41% vs. 36%; hazard ratio (HR) .97; 95% confidence interval (CI) .88–1.08, P = .57]. Surgery improved survival compared with conservative management in the low TRI-SCORE category (72% vs. 44%; HR .27; 95% CI .20–.37, P &lt; .0001), but not in the intermediate (36% vs. 37%; HR 1.17; 95%CI .98–1.40, P = .09) or high categories (20% vs. 24%; HR 1.06; 95% CI .91–1.25, P = .45). Both repair and replacement improved survival in the low TRI-SCORE category (84% and 61% vs. 44%; HR .11; 95% CI .06–.19, P &lt; .0001, and HR .65; 95% CI .47–.90, P = .009). Repair showed benefit in the intermediate category (59% vs. 37%; HR .49; 95% CI .35–.68, P &lt; .0001) while replacement was possibly harmful (25% vs. 37%; HR 1.43; 95% CI 1.18–1.72, P = .0002). Conclusions Higher survival rates were observed with repair than replacement and benefit of intervention declined as TRI-SCORE increased with no benefit of any type of surgery in the high TRI-SCORE category. These results emphasize the importance of timely intervention and patient selection to achieve the best outcomes and the need for randomized controlled trials.
Core outcomes in nerve surgery: development of a core outcome set for common peroneal (fibular) neuropathy
Wilson, Thomas J. , Ali, Zarina S. , Davis, Gavin A , Desai, Ketan, Garozzo, Debora, Guedes, Fernando , Jack, Megan M. , Jacques, Line , Kretschmer, Thomas , Midha, Rajiv, Puffer, Ross C. , Rasulić, Lukas , Ray, Wilson Z. , Rizk, Elias , Rodríguez-Aceves, Carlos Alberto , Shapira, Yuval, Spinner, Robert J. , Zager, Eric L. , Davis, Gavin A. , Dengler, Nora F. , Mahan, Mark A , Pondaag, Willem , Smith, Brandon W. , Socolovsky, Mariano

Mayo Clinic

Journal of Neurosurgery | August 17, 2024 | Volume: No volume available | Issue: No issue available | Pages: 1-9

10.3171/2024.5.jns24614 | PMID 39151186 Get It

OBJECTIVE Common peroneal (fibular) neuropathy is the most common mononeuropathy of the lower extremity. Despite this, there are surprisingly few studies on the topic, and a knowledge gap remains in the literature. As one attempts to address this knowledge gap, a core outcome set (COS) is needed to guide the planning phases of future studies to allow synthesis and comparability of these studies. The objective of this study was to develop the COS–common peroneal neuropathy (CoPe) using a modified Delphi approach. METHODS A 5-stage approach was used to develop the COS-CoPe: 1) stage 1, consortium development; 2) stage 2, a literature review to identify potential outcome measures; 3) stage 3, a Delphi survey to develop consensus on outcomes for inclusion; 4) stage 4, a Delphi survey to develop definitions; and 5) stage 5, a consensus meeting to finalize COS and definitions. The study followed the COS–STAndards for Development (COS-STAD) recommendations. RESULTS The Core Outcomes in Nerve Surgery (COINS) Consortium comprised 23 participants, all neurological surgeons, representing 13 countries. The final COS-CoPe consisted of 31 data points/outcomes covering domains of demographics, diagnostics, patient-reported outcomes, motor/sensory outcomes, and complications. Appropriate instruments, methods of testing, and definitions were set. The consensus minimum duration of follow-up was 12 months. The consensus optimal time points for assessment were preoperatively and 3, 6, 12, and 24 months postoperatively. CONCLUSIONS The COINS Consortium developed a consensus COS and provided definitions, methods of implementation, and time points for assessment. The COS-CoPe should serve as a minimum set of data that should be collected in all future neurosurgical studies on common peroneal neuropathy. Incorporation of this COS should help improve consistency in reporting, data synthesis, and comparability, and should minimize outcome reporting bias.
Blood–brain barrier dysfunction in aging is mediated by brain endothelial senescence
Novo, João P. , Gee, Lucy, Caetano, Carolina A., Tomé, Inês , Vilaça, Andreia , Jurk, Diana , Rosa, Susana , Ferreira, Lino , Caetano, Carolina , Jurk, Diana , Ferreira, Lino , Zglinicki, Thomas von , Moreira, Irina Sousa

Mayo Clinic

Aging Cell | August 15, 2024 | Volume: 23 | Issue: 9 | Pages: No page available

10.1111/acel.14270 | PMID 39143890 Get It

AbstractBBB dysfunction during aging is characterized by an increase in its permeability and phenotypic alterations of brain endothelial cells (BECs) including dysregulation of tight junction's expression. Here we have investigated the role of BEC senescence in the dysfunction of the BBB. Our results suggest that the transition from young to aged BBB is mediated, at least in part by BEC senescence.